News

J B Chemicals & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 April 2026.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 31,160 equity shares under ESOS on 19 February 2026. Consequently, the issued, subscribed and paid-up capital has increased from 16,05,27,546 equity shares of Re. 1 each to 16,05,58,706 equity shares of Re. 1 each. Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 5 February 2026, inter alia, have recommended the interim dividend of Rs 12.7 per equity Share (i.e. 1270%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 37,84,100 equity shares under ESOS on 21 January 2026. Consequently, the issued, subscribed and paid-up capital has increased from 15,66,50,956 equity shares of Re. 1 each to 16,04,35,056 equity shares of Re. 1 each. Powered by Capital Market - Live News